» Articles » PMID: 37759210

Oral Manifestations of COVID-19 in Unvaccinated Patients: a Cross-sectional Study

Overview
Journal BMC Oral Health
Publisher Biomed Central
Specialty Dentistry
Date 2023 Sep 27
PMID 37759210
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Early studies have highlighted the possible development of dysgeusia and anosmia in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, and these manifestations should be considered a potential indication of coronavirus disease 19 (COVID-19). As potential contributors to these symptoms, dentists should perform careful oral and oropharyngeal examinations and document suspicious oral lesions in patients with COVID-19, especially in those who complain of loss of taste and smell. The study's objective was to assess the prevalence of oral manifestations among ambulatory unvaccinated symptomatic patients with suspected COVID-19 during the acute phase of the disease.

Methods: This cross-sectional study evaluated oral manifestations in adults (aged ≥ 18 years) with suspected and confirmed SARS-CoV-2 infection. Chi-square and Fisher's exact tests were used to compare data between the groups (rRT-PCR-positive and rRT-PCR-negative patients).

Results: One hundred thirty-six participants were included. Most were female (n = 79; 58.1%), with a mean age of 39.53 (± 14.17) years. Of these, 54 (39.7%) had a positive rRT-PCR test, and 82 (60.3%) had negative rRT-PCR results. Oral manifestations were observed in 40 participants (74.1%) in the rRT-PCR-positive group and 67 participants (81.7%) in the rRT-PCR-negative group. The most common oral manifestations were xerostomia (n = 85; 62.5%) and dysgeusia/ageusia (n = 57; 41.9%). Different rates of gingivitis (n = 12; 22.2% vs. n = 5; 6.1%; p = 0.005) and halitosis (n = 7; 13.0% vs. n = 1; 1.2%; p = 0.007) were observed between the rRT-PCR-positive and -negative groups, respectively. Mouth ulcers, glossitis, tongue coating, and petechiae were reported in both groups without significant differences.

Conclusions: A high prevalence of oral manifestations was observed in symptomatic patients with suspected or confirmed COVID-19.

Clinical Relevance: This study highlights the importance of routine oral examinations by dentists as part of the multidisciplinary care of COVID-19 patients.

Citing Articles

Unveiling the Oral Lesions, Dysgeusia and Osteonecrosis Related to COVID-19: A Comprehensive Systematic Review.

Aliberti A, Gasparro R, Mignogna M, Canfora F, Spagnuolo G, Sammartino G J Clin Med. 2025; 14(4).

PMID: 40004799 PMC: 11856591. DOI: 10.3390/jcm14041267.


Viral infection and antiviral immunity in the oral cavity.

Hickman H, Moutsopoulos N Nat Rev Immunol. 2024; .

PMID: 39533045 DOI: 10.1038/s41577-024-01100-x.


Seroprevalence of IgM/IgG and Neutralizing Antibodies against SARS-CoV-2 in Unvaccinated Young Adults from Mexico Who Reported Not Having Had a Previous COVID-19 Infection.

Padilla-Borquez D, Matuz-Flores M, Hernandez-Bello J, Sanchez-Zuno G, Garcia-Arellano S, Oregon-Romero E Can J Infect Dis Med Microbiol. 2024; 2024:8871439.

PMID: 38384428 PMC: 10881245. DOI: 10.1155/2024/8871439.

References
1.
Sharma S, Kumar V, Chawla A, Logani A . Rapid detection of SARS-CoV-2 in saliva: can an endodontist take the lead in point-of-care COVID-19 testing?. Int Endod J. 2020; 53(7):1017-1019. PMC: 7267301. DOI: 10.1111/iej.13317. View

2.
Herrera D, Serrano J, Roldan S, Sanz M . Is the oral cavity relevant in SARS-CoV-2 pandemic?. Clin Oral Investig. 2020; 24(8):2925-2930. PMC: 7309196. DOI: 10.1007/s00784-020-03413-2. View

3.
Xu R, Cui B, Duan X, Zhang P, Zhou X, Yuan Q . Saliva: potential diagnostic value and transmission of 2019-nCoV. Int J Oral Sci. 2020; 12(1):11. PMC: 7162686. DOI: 10.1038/s41368-020-0080-z. View

4.
McPhillips L, MacSharry J . Saliva as an alternative specimen to nasopharyngeal swabs for COVID-19 diagnosis: Review. Access Microbiol. 2022; 4(5):acmi000366. PMC: 9394527. DOI: 10.1099/acmi.0.000366. View

5.
Azzi L, Maurino V, Baj A, Dani M, dAiuto A, Fasano M . Diagnostic Salivary Tests for SARS-CoV-2. J Dent Res. 2020; 100(2):115-123. PMC: 7604673. DOI: 10.1177/0022034520969670. View